BIT's 11th World Congress of Regenerative Medicine & Stem Cell (RMSC-2017)
Conference Report of RMSC-2017
Organized by World High Technology Society (WHTS), The 11th Annual World Congress of Regenerative Medicine & Stem Cell-2017 was held successfully at Holiday Inn Singapore Atrium during November 14-16, 2017. Ms. Annekathrin Bigus, CEO and Expert, ABT for you, Germany moderated opening ceremony and Dr. Kibret Mequanint, Professor, Department of Chemical and Biochemical Engineering, The University of Western Ontario, Canada delivered an opening address on behalf of all participants. As the keynote speakers, Dr. William Whitford, Strategic Solutions Leader, Cell Culture, Bioprocess, GE Healthcare, USA; Dr. Faribourz Payvandi, Chief Scientific Officer, 3D Biotek LLC, USA; Dr. Takahiro Ochiya, Chief, Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Japan; Dr. Shai Yarkoni, CEO, Cellect Biotechnology Ltd., Israel; Dr. Jenny Y. Wang, Head, Cancer and Stem Cell Laboratory, University of New South Wales, Australia have presented their excellent talks and warmly discussed with the audiences at the Keynote Forum. RMSC-2017 included 21 Parallel sessions, we felt extremely happy to bring so many old and new friends to the beautiful country, Singapore and believed all of them sensed the warm hospitality, happy holiday environment so as to let them get the feeling at home. We were also so excited to see many innovative scientific and technological breakthroughs have been made by more than 140 speakers from nearly 31 countries, who are involved in stem cell therapy, biomaterials, tissue engineering and other related applications. Meanwhile, there were over 60 professional audiences who have participated in our conference as well. Depending on the warmly support and creative efforts from all the participants, we are confident in organizing RMSC-2018, which must be better and more successful undoubtedly in Xi’an, China next November 7-9, 2018.
Introduction to RMSC-2017
The first RMSC is held in 2009, which always bring innovation and supersize every year in China. Good news, the committee set a new conference program with feedback and survey from thousands of participates, RMSC-2017 will create a landmark trend of Regenerative Medicine worldwide in Singapore. The development of Regenerative Medicine has highly attracted the world’s attention and, with demand increasing, theories as well as technology improving and governmental support strengthening, it has gradually become a hot topic in the field of international biology and medicine. Stem Cell, one of the most important subjects in the domain of regenerative medicine, has become a global focus because of its great potential in research and application. It can help to cure leukemia, congenital metabolic disease, certain solid tumor, diabetes, heart disease, cerebral palsy and other diseases. Stem cell is the most important subject from Regenerative Medicine and also will be the hottest topic in the recent decade years.
Renowned Speakers of RMSC-2017
Dr. Takahiro Ochiya, Chief, National Cancer Center Research Institute, Japan Mr. Ajan Reginald, CEO, Celixir & Cell Therapy LTD, UK
Ms. Annekathrin Bigus, CEO and Expert, ABT for you, Germany Dr. Dong-Hun Woo, Chief Technology Officer, NEXEL Co., Ltd., South Korea
Dr. Tobias Winkler, Head of Musculoskeletal Cell Therapy, Julius Wolff Institute & Berlin-Brandenburg, Germany Dr. Silvia Bradamante, Research Director, CNR-ISTM, University of Milan, Italy
Dr. Lene Broeng Oddershede, Professor/Center Leader, Niels Bohr Institute, University of Copenhagen, Denmark Dr. Frank Emmrich, Professor, Fraunhofer-Institute for Cell Therapy and Immunology, Germany
  Dr. Matteo Carlo Ferrari, Head, Hospitalist Perioperative Medicine Service, Orthopaedic and Rehabilitation Center, Humanitas Research Hospital; Adjunct Clinical Professor and Member, the Open Faculty of Medicine and Surgery Humanitas University, Italy Dr. Fabin Han, Professor and Director, Centre for Stem Cells and Regenerative Medicine, The Institute for Tissue Engineering & Regenerative Medicine, Shandong University/Liaocheng People’s Hospital, China
Dr. Geeta Shroff, Director, Nutech Mediworld, India Dr. Haim Shtarker, Director, Department of Orthopaedics A and Unit of Pediatric Orthopaedics, Galilee Medical Center, Israel
Dr. Simon Pardinas Lopez, Director, Clínica Médico Dental Pardiñas; Research Leader, Fundación Clínica Pardiñas, Spain Dr. Rajamani Lakshminarayanan, Principal Investigator II, Singapore Eye Research Institute; Assistant Professor, Academic Clinical Program in Visual Science and Ophthalmology Duke-NUS, Singapore
Dr. Iryna Sudoma, Scientific Director, Reproductive Medicine Clinic Nadiya, Ukraine Dr. Joseph Purita, Director, Stem Cell Centers of America, USA
Dr. Kunbo Wang, Professor, Institute of Cotton Research, Chinese Academy of Agricultural Sciences, China Dr. Azel Zine, Professor, Montpellier University, France
Dr. Udi Sarig, Senior Research Fellow, Nanyang Technological University (NTU), Singapore Dr. Hyeon-Min Bae, Professor, Korea Advanced Institute of Science and Technology, South Korea
Dr. Yongxiang Zhao, Professor, Guangxi Medical University, China Dr. Carlos Omar Gonzalez-Moran, Professor, University Center UAEM Mexico Valley, Mexico
Dr. Jin Ho Lee, Professor, Hannam University, South Korea Dr. Edda Tobiasch, Professor, Bonn-Rhine-Sieg University of Applied Sciences, Germany
Dr. Shi-Ming Tu, Professor, University of Texas MD Anderson Cancer Center, USA Dr. Michael W. Weiner, Professor, University of California, USA
Dr. Rolf Bodmer, Professor, Development, Aging and Regeneration Program, Sanford Burnham Prebys Medical Discovery Institute, USA Dr. Richard H. W. Funk, Professor, TU-Dresden, Germany
Dr. Arkadiusz Orzechowski, Professor, -SGGW, Poland Dr. Dianrong Gong, Professor, Department of Neurology, Liaocheng People's Hospital, China
Dr. Song G Zheng, Professor and Director, Milton S. Hershey Medical Center at Penn State University, USA Dr. Wolf-Karsten Hofmann, Professor, Heidelberg University, Germany
Exhibition and Sponsorship

RMSC-2017 provides an ideal platform to showcase your new technologies and products in Singapore. It is developed to maximize your exposure, generate new leads, build brand awareness, and solidify business relations.

RMSC-2017 is one of the most effective international marketing platforms in the field of Regenerative Medicine & Stem Cell, which offers a wide range of sponsoring categories for branding and highlighting your company in order to achieve the best publicity.

Introduction to Singapore

Singapore has often been described as another Dubai in the making, and, where there is a slight element of truth to the statement, that is not all that Singapore is about. There is a lot more to the city-state than fancy shopping malls and luxury hotels. Singapore also boasts a vibrant history, and several family- and pocket-friendly public spaces, making it worth your while to explore this mini-Dubai.

Past Conferences
News Updates
● Tentative Program Released
● WeChat for Chinese Released
● Speaking proposals are now being accepted, download the abstract format right now
Operating Organization
Overseas Cooperate Journal
WeChat for Chinese
Official Travel Agency
Media Partners

BIT's Upcoming Events
©2016-2017 All rights reserved by BIT Congress Inc.
Contact Us: Tel: 0086-411-84799609-801-801, : 0086-411-84799609-801